Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Endocrinology | Family Medicine | Geriatrics | Internal Medicine | Nursing | Pharmacy | Journal

Back to Journal Articles

Review: Omega-3s Do Not Reduce Risk of Cardio Events

Last Updated: September 11, 2012.

 

Meta-analysis of 20 studies shows no correlation with mortality, cardiac mortality, MI, stroke

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Supplementation with omega-3 polyunsaturated fatty acids is not associated with a statistically significant reduction in major cardiovascular end points, according to research published in the Sept. 12 issue of the Journal of the American Medical Association.

TUESDAY, Sept. 11 (HealthDay News) -- Supplementation with omega-3 polyunsaturated fatty acids (PUFAs) is not associated with a statistically significant reduction in major cardiovascular end points, according to research published in the Sept. 12 issue of the Journal of the American Medical Association.

Evangelos C. Rizos, M.D., Ph.D., from the University Hospital of Ioannina in Greece, and colleagues conducted a systematic review and meta-analysis of randomized clinical trials that assessed the effect of omega-3 on all-cause mortality, cardiac death, sudden death, myocardial infarction, and stroke.

Twenty studies involving 68,680 patients were included in the analysis, which reported 7,044 deaths; 3,993 cardiac deaths; 1,150 sudden deaths; 1,837 myocardial infarctions; and 1,490 strokes. The researchers found that when all supplement studies were considered there was no statistically significant association for any of the outcomes.

"In conclusion, omega-3 PUFAs are not statistically significantly associated with major cardiovascular outcomes across various patient populations," the authors write. "Our findings do not justify the use of omega-3 as a structured intervention in everyday clinical practice or guidelines supporting dietary omega-3 PUFA administration."

One author disclosed financial ties to industry but no ties to companies that manufacture or market omega-3 supplements.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: No Superior Method of Adjusting Inhaled Steroids in Asthma Next: Genomic Alterations ID'd in Lung Squamous Cell Carcinoma

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.